Berry Genomics (000710.SZ) released its performance for the first three quarters, with a net loss attributable to the parent company of 52.5637 million yuan.

Zhitong Finance APP News, Berry Gene (000710.SZ) released the third quarter report for 2025. In the first three quarters, the company achieved operating income of 686 million yuan, a year-on-year decrease of 16.65%. The net loss attributable to shareholders of the listed company was 52.5637 million yuan. After deducting non-recurring gains and losses, the net loss attributable to shareholders of the listed company was 53.7914 million yuan.